B-Trust Meditech
A veterinary med-tech startup specializing in the development and manufacturing of metal 3D-printed orthopedic implants, notably Korea's first domestically approved artificial knee joints for animals.
- CEO / Founder
- Seo Jeong-woo
- Team Size
- 4-10
- Stage
- Commercial
- Total Funding
- Undisclosed
- Latest Round
- Seed
- Key Investors
- Individual Angel Investors, Government-backed Tech Programs (TIPS candidate)
Technology & Products
Key Products
["Rotating Hinge-type Artificial Knee Joint (Metal 3D-printed)","Veterinary Artificial Hip Joint System","Artificial Patellar Groove (for patellar luxation treatment)","Customized 3D-printed Veterinary Implants"]
Technological Advantage
Leverages advanced metal additive manufacturing (Titanium and Cobalt-Chrome alloys) and human-level biomechanical verification to create durable, patient-optimized implants that offer significant cost advantages over imported products.
Differentiation
Value Proposition
Offers high-precision, human-grade biocompatible implants that reduce reliance on expensive imports, providing superior anatomical fit and biomechanical stability for companion animals.
How They Differentiate
B-Trust Meditech differentiates itself through 'Human-to-Pet' technology transfer, utilizing human-grade orthopedic biomechanics and metal additive manufacturing (Titanium/Cobalt-Chrome). They achieved a technical moat by being the first in South Korea to obtain product approval for 'rotating hinge-type' artificial knee joints, which offer superior anatomical stability compared to standard fixed-hinge imports.
Market & Competition
Target Customers
Veterinary specialty hospitals, orthopedic surgeons in animal clinics, and pet owners requiring advanced joint replacement surgery for dogs and cats.
Industry Verticals
["Veterinary Medicine","Medical Device Manufacturing","Additive Manufacturing (Metal 3D Printing)","Pet Healthcare"]
Competitors
Bio-Orthofix (바이오오소픽스); Pluon (플루온); BioMedtrix (Global/Import)
Growth & Milestones
Growth Metrics
Successfully moved from R&D to commercial stage in late 2024 following domestic regulatory approval; Team size 4-10 employees.
Major Milestones
["Founded in 2022 focusing on veterinary medical device localization.","Developed a diverse portfolio including veterinary artificial hip joints and patellar groove implants.","Obtained South Korea's first domestic product approval for metal 3D-printed rotating hinge-type artificial knee joints for animals in late 2024.","Established a GMP-certified quality management system specifically for 3D-printed veterinary implants."]
Notable Customers
Seoul National University Veterinary Medical Teaching Hospital (Clinical Verification); Major secondary veterinary referral centers in South Korea